Banner

Gynecology Drugs Global Market Report 2022 – By Therapeutics (Hormonal Therapy, Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception), By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)– Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 150 | Published : October 2022 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The gynecology drugs market consists of sales of gynecology drugs services by entities (organizations, sole traders, and partnerships) that manufacture gynecology drugs which are used to treat gynecological diseases which include conditions affecting the uterus, ovaries, and their appendages.

The main types of therapeutics in gynecology drugs are hormonal therapy and non-hormonal therapy. Hormonal therapy is a treatment that adds, blocks or removes hormones to slow or stop the growth of cancer cells that need hormones to grow. Non-hormonal therapy involves the usage of anti-infective, anti-inflammatory agents, lubricants, moistures, antidepressants, gabapentin, clonidine and others. Gynecology drugs are used for gynecology cancers, menopausal disorder, polycystic ovary syndrome, contraception and others and distributed through hospital pharmacies, retail pharmacies and online pharmacies.

The gynecology drugs market research report is one of a series of new reports from The Business Research Company that provides gynecology drugs market statistics, including gynecology drugs industry global market size, regional shares, competitors with a gynecology drugs market share, detailed gynecology drugs market segments, market trends and opportunities, and any further data you may need to thrive in the gynecology drugs industry. This gynecology drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global gynecology drugs market is expected to grow from $22.22 billion in 2020 to $24.68 billion in 2021 at a compound annual growth rate (CAGR) of 11.07%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting manyevery markets across the globe. The gynecology drugs market is expected to reach $31.21 billion in 2025 at a CAGR of 6.05%.

The rise in the number of women suffering from ovarian cancer would drive the growth of the global gynecological drugs market. For instance, according to Globocan, it is estimated that the global incidence of ovarian cancer will increase from 295,414 in 2018 to 434,184 by 2040. The increasing incidence of ovarian cancer would boost the market for gynecological drugs in the forecast period.

Alternative treatment methods and natural remedies are increasingly becoming popular globally which is expected to have a negative impact on the revenues of gynecological drug companies. Treatments in the fields of homoeopathy, Ayurveda, yoga, acupuncture, sujok therapy are gaining popularity and slowly replacing some traditional hospital practices. For instance, Ayurvedic medicine, an ancient Indian system of medicine uses a range of techniques and treatments for gynecological cancer. Many herbs used in Ayurveda have anti-cancer properties, for example, Curcumin, Holy Basil is said to inhibit the growth of cancerous cells and Ayurvedic gynecological procedures like Agnikarma help treat cervical erosion. This growing adoption of alternative treatments is expected to have a negative impact on the growth of the market.

Drug manufacturers are investing in developing personalized cancer vaccines, including gynecological cancers, and few have reached clinical trial phases. Pharmaceutical companies are combining genetic sequencing and precision medicine to create new drug therapies and cancer treatments that are designed to treat specific patients. For instance, in 2016, Merck, an American pharmaceutical company collaborated with Moderna Therapeutics, an American biotech company pioneer of messenger RNA Therapeutics to develop and commercialize novel messenger RNA (mRNA)-based personalized cancer vaccines. In 2019, Moderna announced the result of the ongoing Phase 1 clinical study in patients with both resected (adjuvant) and unresected (advanced) solid tumours. The results were positive when mRNA mRNA personalized cancer vaccine (PCV) mRNA-4157, was given alone or in combination with Merck pembrolizumab (KEYTRUDA®). Currently, the vaccine is in phase 2 clinical trial.

In January 2020, India-based capital market company True North announced the acquisition of India-based Glenmark Pharmaceuticals Ltd gynecology business in India and Nepal for $16.2 million (INR 115 crore). Through this acquisition, True North aims to further grow the gynecology portfolio of Glenmark and expanding presence in multiple geographies.

Major players in the gynecology drugs market are Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co. Inc., Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc., Lupin Pharmaceuticals Inc., Ferring Holding SA, Johnson & Johnson, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., and Sanofi.

North America was the largest region in the gynecology drugs market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the gynecology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gynecology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The global gynecology drugs market is segmented -

1) By Therapeutics: Hormonal Therapy, Non-Hormonal Therapy

2) By Indication: Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Others

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Table Of Contents

    1. Executive Summary

    2. Gynecology Drugs Market Characteristics

    3. Gynecology Drugs Market Trends And Strategies

    4. Gynecology Drugs Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Gynecology Drugs Market

    4.2. Ukraine-Russia War Impact On Gynecology Drugs Market

    4.3. Impact Of High Inflation On Gynecology Drugs Market

    5. Gynecology Drugs Market Size And Growth

    5.1. Global Gynecology Drugs Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Gynecology Drugs Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Gynecology Drugs Market Segmentation

    6.1. Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hormonal Therapy

    Non-Hormonal Therapy

    6.2. Global Gynecology Drugs Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Gynecology Cancers

    Menopausal Disorder

    Polycystic Ovary Syndrome

    Contraception

    Others

    6.3. Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Gynecology Drugs Market Regional And Country Analysis

    7.1. Global Gynecology Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Gynecology Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Gynecology Drugs Market  

    8.1. Asia-Pacific Gynecology Drugs Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Gynecology Drugs Market  

    9.1. China Gynecology Drugs Market Overview  

    9.2. China Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Gynecology Drugs Market  

    10.1. India Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Gynecology Drugs Market  

    11.1. Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Gynecology Drugs Market  

    12.1. Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Gynecology Drugs Market  

    13.1. Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Gynecology Drugs Market  

    14.1. South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Gynecology Drugs Market  

    15.1. Western Europe Gynecology Drugs Market Overview

    15.2. Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Gynecology Drugs Market  

    16.1. UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Gynecology Drugs Market  

    17.1. Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Gynecology Drugs Market  

    18.3. France Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Gynecology Drugs Market  

    19.1. Eastern Europe Gynecology Drugs Market Overview

    19.2. Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Gynecology Drugs Market  

    20.1. Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Gynecology Drugs Market  

    21.1. North America Gynecology Drugs Market Overview

    21.2. North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Gynecology Drugs Market  

    22.1. USA Gynecology Drugs Market Overview

    22.2. USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Gynecology Drugs Market  

    23.1. South America Gynecology Drugs Market Overview

    23.2. South America Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Gynecology Drugs Market  

    24.1. Brazil Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Gynecology Drugs Market  

    25.1. Middle East Gynecology Drugs Market Overview

    25.2. Middle East Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Gynecology Drugs Market  

    26.1. Africa Gynecology Drugs Market Overview

    26.2. Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Gynecology Drugs Market Competitive Landscape And Company Profiles

    27.1. Gynecology Drugs Market Competitive Landscape

    27.2. Gynecology Drugs Market Company Profiles

    27.2.1. Hoffmann-La Roche Ltd.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Merck & Co., Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Allergan

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. AstraZeneca

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Gynecology Drugs Market

    29. Gynecology Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Gynecology Drugs Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Gynecology Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Gynecology Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: China, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: India, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Japan, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: Australia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Indonesia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: South Korea, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Western Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: UK, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Germany, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: France, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Eastern Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Russia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: North America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: USA, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: South America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Brazil, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Middle East, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Africa, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Hoffmann-La Roche Ltd. Financial Performance
  • Table 28: Pfizer Inc Financial Performance
  • Table 29: Merck & Co., Inc. Financial Performance
  • Table 30: Allergan Financial Performance
  • Table 31: AstraZeneca Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Gynecology Drugs Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Gynecology Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Gynecology Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: China, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: India, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Japan, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: Australia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Indonesia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: South Korea, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Western Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: UK, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Germany, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: France, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Eastern Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Russia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: North America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: USA, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: South America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Brazil, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Middle East, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Africa, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Hoffmann-La Roche Ltd. Financial Performance
  • Figure 28: Pfizer Inc Financial Performance
  • Figure 29: Merck & Co., Inc. Financial Performance
  • Figure 30: Allergan Financial Performance
  • Figure 31: AstraZeneca Financial Performance
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth
Best Prospects in the Global Hormonal Contraceptives Market and Strategies for Growth – Includes Hormonal Contraceptives Market Share
Take Up Global Biosimilars Market Opportunities With Clear Industry Data – Includes Biosimilars Market Size
Take Up Global Nucleic Acid Based Gene Therapy Market Opportunities with Clear Industry Data – Includes Nucleic Acid Based Gene Therapy Market Size
Global Enzyme Inhibitor Market Overview And Prospects – Includes Enzyme Inhibitor Market Share
Gynecology Medical Lasers Global Market Report 2022 – By Product Type (CO2 Laser, KTP–Argon Laser, Nd:YAG Laser), By Application (Colposcopy, Laparoscopy, Hysteroscopy), By End-User (Hospital, Specialized Clinics, Ambulatory Surgical Centers, Medical Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Portable Ultrasound Devices Market - By Type of Device (Mobile Ultrasound Devices And Handheld Ultrasound Devices), By End User ( Cardiovascular, Obstetrics / Gynecology, Gastro, Musculoskeletal And Point Of Care), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
3D Medical Imaging Devices Global Market Report 2022 – By Type (Ultrasound, X-ray, CT Scan, Other Types), By End User (Diagnostic Centers, Hospitals, Research Centers), By Application (Gynecology and Obstetrics, Cardiology, Neurology, Orthopedics, Oncology) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Electrosurgical Devices And Equipment Global Market Report 2022 – By Product (Electrosurgery Generators, Electrosurgery Instruments & Accessories, Argon and Smoke Management Systems), By End User (Hospitals, Specialized Clinics, Ambulatory Surgery Centers), By Application (General Surgery, Gynecology Surgery, Urologic Surgery, Orthopedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Endoscopy Devices And Equipment Global Market Report 2022 – By Product (Endoscope, Endoscopy Operative Devices , Endoscopy Visualization Systems), By End-User (Hospitals, Clinics), By Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology endoscopy, Neuroendoscopy, Gastrointestinal endoscopy, Obstetrics/gynecology endoscopy, ENT endoscopy) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Medical And Diagnostic Laboratory Services Global Market Report 2022 – By Type (Diagnostic Imaging Centers, Medical Laboratory Services), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology), By End User Gender (Male, Female), By Type of Expenditure (Public, Private) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Minimal Invasive Surgery Devices Global Market Report 2022 – By Product Type (Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices), By Application (Laparoscopy, Cardiovascular, Cosmetic Surgery, Orthopedic Surgery, Obstetrics And Gynecology, Ophthalmology, Neurosurgery, Urology, Other Applications), By End Users (Hospitals, Ambulatory Surgical Centers (ASCS), Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Polycystic Ovarian Syndrome Treatment Global Market Report 2022 – By Drug Type (Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors), By Surgery Type (Ovarian Wedge Resection, Laparoscopic Ovarian Drilling), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Gynecology Centers, Feminist Health Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report